Literature DB >> 21667221

The Consequence of a Founder Effect: CCR5-∆32, CCR2-64I and SDF1-3'A Polymorphism in Vlach Gypsy Population in Hungary.

Emese Juhász1, Judit Béres, Szilvia Kanizsai, Károly Nagy.   

Abstract

Frequencies of genetic polymorphisms of the three most frequent HIV-1 resistance-conferring alleles playing an important role in HIV-1 pathogenesis were analysed in Vlach Gypsy populations living in Hungary, as the largest minority. Mutations in the encoding genes, such as CCR5-∆32, CCR2-64I and SDF1-3'A are shown to result in protective effects against HIV-1 infection and disease progression. 560 samples collected from Vlach Gypsy individuals living in 6 North-East Hungarian settlements were genotyped by PCR-RFLP method. Overall allele frequencies of CCR5-∆32, CCR2-64I and SDF1-3'A were found as 0.122, 0.186 and 0.115 respectively. All the observed genotype frequencies were in accordance with Hardy-Weinberg equilibrium . In regions, however, Vlach Gypsies live in majority and in ethnically homogenous communities, a higher CCR5-∆32 mutations were found, with allele frequencies of 0.148 and 0.140 respectively, which are remarkably higher than those in general Hungarian people, and ten times higher than in regions of North-Western India from where present day Hungarian Gypsies originated in the Middle Ages. In the background of this higher CCR5-∆32 allele frequency in the population analysed in our study a genetic founder effect could be assumed. Allele frequency of CCR2-64I was found to be among the highest in Europe. SDF1-3'A allele frequency in Vlach Gypsies was significantly lower than in ethnic Hungarians. 63% of the total 560 individuals tested carried at least one of the mutations studied. These results could partially explain the low incidence of HIV/AIDS among Vlach Gypsies in Hungary.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21667221     DOI: 10.1007/s12253-011-9425-4

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  29 in total

1.  CCR5Delta32 59537-G/A promoter polymorphism is associated with low translational efficiency and the loss of CCR5Delta32 protective effects.

Authors:  Qingwen Jin; Lokesh Agrawal; L Meyer; R Tubiana; Ioannis Theodorou; Ghalib Alkhatib
Journal:  J Virol       Date:  2007-12-19       Impact factor: 5.103

2.  Frequency of the HIV-1 resistance CCR5 deletion allele in Hungarian newborns.

Authors:  C Szalai; A Czinner; A Császár; T Szabó; A Falus
Journal:  Eur J Pediatr       Date:  1998-09       Impact factor: 3.183

3.  Distribution of CCR5delta32, CCR2-64I and SDF1-3'A and plasma levels of SDF-1 in HIV-1 seronegative North Indians.

Authors:  Romsha Verma; Radha Ballabh Gupta; Kalpana Singh; Rama Bhasin; Abhay Anand Shukla; Shyam S Chauhan; Kalpana Luthra
Journal:  J Clin Virol       Date:  2007-01-19       Impact factor: 3.168

4.  Distribution of three HIV-1 resistance-conferring polymorphisms (SDF1-3'A, CCR2-641, and CCR5-delta32) in global populations.

Authors:  B Su; G Sun; D Lu; J Xiao; F Hu; R Chakraborty; R Deka; L Jin
Journal:  Eur J Hum Genet       Date:  2000-12       Impact factor: 4.246

Review 5.  Patterns of ethnic diversity among the genes that influence AIDS.

Authors:  Cheryl Winkler; Ping An; Stephen J O'Brien
Journal:  Hum Mol Genet       Date:  2004-02-05       Impact factor: 6.150

6.  Combined genotypes of CCR5, CCR2, SDF1, and HLA genes can predict the long-term nonprogressor status in human immunodeficiency virus-1-infected individuals.

Authors:  M Magierowska; I Theodorou; P Debré; F Sanson; B Autran; Y Rivière; D Charron; D Costagliola
Journal:  Blood       Date:  1999-02-01       Impact factor: 22.113

7.  Genetically determined neuromuscular disorders of some Roma families living in Hungary.

Authors:  Laszlo Aranka; Mayer Peter; Kobor Jeno; Racz Katalin; Talosi Gyula; Endreffy Emoke; Herczegfalvi Agnes; Hortobagyi Tibor; Tiszlavicz Laszlo; Bereg Edit; Katona Marta; Szabo Janos; Karcagi Veronika
Journal:  Ideggyogy Sz       Date:  2009-01-30       Impact factor: 0.427

Review 8.  Genetic polymorphisms in the chemokine and chemokine receptors: impact on clinical course and therapy of the human immunodeficiency virus type 1 infection (HIV-1).

Authors:  E M V Reiche; A M Bonametti; J C Voltarelli; H K Morimoto; M A E Watanabe
Journal:  Curr Med Chem       Date:  2007       Impact factor: 4.530

Review 9.  Human genes that limit AIDS.

Authors:  Stephen J O'Brien; George W Nelson
Journal:  Nat Genet       Date:  2004-06       Impact factor: 38.330

10.  CCR2b-64I allelic polymorphisms in advanced HIV-infected Koreans accelerate disease progression.

Authors:  Byeong-Sun Choi; Jang-Hoon Choi; Sung Soon Kim; Mee-Kyung Kee; Joo-Shil Lee
Journal:  AIDS Res Hum Retroviruses       Date:  2007-06       Impact factor: 2.205

View more
  3 in total

1.  Distribution of CCR-5Δ32, CCR2-64I, and SDF-1-3'A alleles among Jordanians.

Authors:  Omar F Khabour; Laila J Abu-Haweleh; Karem H Alzoubi
Journal:  AIDS Res Hum Retroviruses       Date:  2012-07-31       Impact factor: 2.205

2.  MARVELD2 (DFNB49) mutations in the hearing impaired Central European Roma population--prevalence, clinical impact and the common origin.

Authors:  Ivica Mašindová; Andrea Šoltýsová; Lukáš Varga; Petra Mátyás; Andrej Ficek; Miloslava Hučková; Martina Sůrová; Dana Šafka-Brožková; Saima Anwar; Judit Bene; Slavomír Straka; Ingrid Janicsek; Zubair M Ahmed; Pavel Seeman; Béla Melegh; Milan Profant; Iwar Klimeš; Saima Riazuddin; Ľudevít Kádasi; Daniela Gašperíková
Journal:  PLoS One       Date:  2015-04-17       Impact factor: 3.240

Review 3.  Association of Diverse Genotypes and Phenotypes of Immune Cells and Immunoglobulins With the Course of HIV-1 Infection.

Authors:  Liuzhe Li; Yan Liu; Miroslaw K Gorny
Journal:  Front Immunol       Date:  2018-11-26       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.